UK clinics told to stop prescribing antidiabetes drugs for weight loss, after shortages-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

UK clinics told to stop prescribing antidiabetes drugs for weight loss, after shortages

Published:2023-07-21 Issue: Volume: Page:p1693
ISSN:1756-1833
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Iacobucci Gareth

Publisher

BMJ

Subject

General Engineering

Reference3 articles.

1. MHRA Central Alerting System. National patient safety alert: shortage of GLP-1 receptor agonists. Jul 2023. https://www.cas.mhra.gov.uk/ViewandAcknowledgment/ViewAlert.aspx?AlertID=103235.

2. Seven days in medicine: 28 Oct to 3 Nov 2020

3. Wegovy: Weight loss drug to be available from GPs in pilot scheme

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disproportionality Analysis From World Health Organization Data on Semaglutide, Liraglutide, and Suicidality;JAMA Network Open;2024-08-20

2. GLP-1 shortages will not resolve this year, EMA warns, amid concern over off-label use;BMJ;2024-06-28

3. Japan initiates market authorization of weight‐loss drug semaglutide under universal health coverage, but with stringent prescription restrictions;Diabetes, Obesity and Metabolism;2024-05-15

4. Existing and emerging GLP-1 receptor agonist therapy: Ramifications for diabetic retinopathy screening;Journal of the Royal College of Physicians of Edinburgh;2024-04-05

5. GLP-1 agonist shortage will last until end of 2024, government warns;BMJ;2024-01-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP